Concepedia

Author

Pamela Kreinest

Mayo Clinic in Florida

Also Known As

P A Kreinest, Pamela A. Kreinest, Pamela Kreinest

10

Publications

1.1K

Citations

8

H-Index

12

Concepts

All Affiliations

Mayo Clinic in FloridaJacksonville CollegeWinnMedMayo ClinicThe University of Texas Medical Branch at Galveston
PK

About

Pamela Kreinest is an author at Mayo Clinic in Florida specializing in medicine, urology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

174

2

Pharmacology

2

2

160

3

Cell Biology

1

1

132

4

Pathology

1

1

14

5

Cancer Cell Biology

1

1

132

Pamela Kreinest

×

8

Publications

1.1K

Citations

8

H-Index

YearCitations

Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma

Michelle L. Gumz, Hongzhi Zou, Pamela Kreinest,

Clinical Cancer Research

2007

304

Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma

Han W. Tun, Laura A. Marlow, Christina A. Von Roemeling,

PLoS ONE

2010

182

A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease

Masahiro Yanagisawa, Huveldt Deborah, Pamela Kreinest,

Journal of Biological Chemistry

2008

173

Pathway analysis of primary central nervous system lymphoma

Han W. Tun, David Personett, Karen A. Baskerville,

Blood

2008

165

Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1

John A. Copland, Laura A. Marlow, Shinichi Kurakata,

Oncogene

2005

132

Oncogenic <i>K‐ras</i> promotes early carcinogenesis in the mouse proximal colon

Shelly R. Calcagno, Shuhua Li, Migdalisel Colon,

International Journal of Cancer

2008

69

The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro

Marie N. Becker, Kevin J. Wu, Laura A. Marlow,

Urologic Oncology Seminars and Original Investigations

2013

28

Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma

Alexander S. Parker, Christine M. Lohse, Kevin J. Wu,

Human Pathology

2006

14

Page 1